As GLP-1 receptor agonists become more common in diabetes and weight management, new concerns are emerging around how GLP-1 medications are managed before surgery. What happens when a medication that slows digestion meets anesthesia? Increasingly, clinicians are asking whether continuing these therapies before surgery could raise aspiration risk. Clear protocols for GLP-1 sur...

Concerns about GLP-1 drug interactions are rising as these therapies gain widespread use in diabetes and obesity management. As more patients start medications like semaglutide and liraglutide, clinicians are asking an important question: how do these drugs affect the absorption of other treatments? Much like slowing traffic on a busy highway, delayed gastric emptying caused ...

Diabetes care can feel like navigating a maze of medications, glucose targets, and lifestyle changes. So how do clinicians ensure patients stay engaged for the long term? Shared decision making in diabetes care offers a practical answer by turning clinical conversations into collaborative partnerships. Instead of simply prescribing treatment, providers and patients work toget...

Early onset type 2 diabetes is no longer rare, and its rise among younger adults raises serious concerns. What happens when a chronic condition that typically appears later in life begins decades earlier? Much like starting a marathon with added weight, younger patients face a longer disease course and a greater cumulative burden of complications. Therefore, understanding the...

Have you ever wondered why the same meal can spike one person’s blood sugar but barely affect another’s? Research into precision nutrition for diabetes is helping answer that question. For years, dietary advice for diabetes followed a general template. However, growing evidence shows that individual responses to food vary widely. As a result, clinicians are beginning to rethi...